Monoclonal antibody treatments available to eligible COVID-positive patients
Starting October 25, monoclonal antibodies will be available to treat clinically appropriate patients who have contracted COVID-19, with the intent of preventing unvaccinated or severely immunosuppressed residents who have contracted…
